The effect of piracetam in preventing combined cisplatin and gentamicin-induced ototoxicity in a guinea pig model

Pain Clinic

Volumn 16, Issue 4, 2004, Pages 427-433

  Altas, Enver ^a,b   Ucuncu, Harun ^a   Aktan, Bulent ^a   Selimoglu, Erol ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Gentamicin; Ototoxicity; Piracetam

Indexed keywords

CISPLATIN; GEMCITABINE; GENTA; PIRACETAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; LATENT PERIOD; MALE; NEUROPROTECTION; NONHUMAN; OTOTOXICITY;

EID: 11244355000     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/1568569042664530     Document Type: Article

References (23)

1. Schweitzer VG, Ototoxicity of chemotherapeutic agents, Otolaryngologic Clin N Am 26, 760-89 (1993).
2. Riggs LC, Brummett RE, Guitjens SK, et al., Ototoxicity resulting from combined administration of cisplatin and gentamicin, Laryngoscope 106, 401-6 (1996).
3. Curtin JP, Hopkins WJ, Rubin SC, et al., Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy, Gynecol Oncol 40, 17-20 (1991).
4. Kohn S, Fradis M, Podoshin L, et al., Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs, Laryngoscope 101, 710-5 (1991).
5. Keating MJ, Bodey GP, Valdivieso M, et al., A randomized comparative trial of three aminoglycosides. Comparison of continuous infusions of gentamicin, amikacin, and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies, Medicine (Baltimore) 58, 159-70 (1979).
6. Yu LC, Shaneyfelt T, Warrier R, et al., The efficacy of ticarcillin-clavulanate and gentamicin as empiric treatment for febrile neutropenic pediatric patients with cancer, Pediatr Hematol Oncol 11, 181-7 (1994).
7. Otto WC, Brawn RD, White LG, et al., Efects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs, Hearing Res 35, 79-85 (1988).
8. Lautermann J, McLaren J, Schacht J, Glutathione protection against gentamicin Ototoxicity depends on nutritional status, Hearing Res 86, 15-24 (1995).
9. Garetz SL, Altschuler RA, Jochen S, Attenuation of gentamicin Ototoxicity by glutathime in the guinea pig in vivo, Hearing Res 77, 81-7 (1994).
10. Rybak LP, Husain K, Whitworth C, et al., Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system, Toxicol Sci 47, 195-202 (1999).
11. Conlon BJ, Aran JM, Erre JP, et al., Attenuation of aminoglycoside- induced cochlear damage with the metabolic antioxidant alpha lipoic acid, Hearing Res 128, 40-4 (1999).
12. Ciges M, Cervilla FF, Crespo PV, et al., Pantothenic acid and coenzyme A in experimental cisplatin-induced ototoxia, Acta Otolaryngol (Stockholm) 116, 263-8 (1996).
13. Conlon BJ, Smith DW, Topical aminoglycoside ototoxicity: attempting to protect the cochlea, Acta Otolaryngol 120, 596-9 (2000).
14. Gabaizadeh R, Staecker H, Liu W, et al., Protection of both auditory hair cell and auditory neurons from cisplatin induced damage, Acta Otolaryngol (Stockholm) 117, 232-8 (1997).
15. Sha SH, Schacht JS, Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant, Hearing Res 142, 34-40 (2000).
16. Campbell KCM, Rybak LP, Meech RP, et al., D-methionine provides excellent protection from cisplatin ototoxicity in the rat, Hearing Res 102, 90-8 (1996).
17. Güneri EA, Şerbetçioglu B, İkiz AÖ, et al., TEOAE monitoring of cisplatin-induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment, Auris Nasus Larynx 28, 9-14 (2001).
18. Li G, Frenz DA, Brahmblatt S, et al., Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy, Neurotoxicology 22, 163-76 (2001).
19. Teranishi M, Nakashima T, Wakabayashi T, Effects of alpha tocopherol on cisplatin-induced ototoxicity in guinea pigs, Hearing Res 151, 61-70 (2001).
20. Moriau M, Crasbom L, Lavenne-Pardonge E, et al., Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects, Arzneimittel Forsch 43, 110-8 (1993).
21. Horvath B, Marton Z, Halmosi R, et al., In vitro antioxidant properties of pentoxiphylline, piracetam and vinpocetine, Clin Neuropharmacol 25, 37-42 (2002).
22. Ingham NJ, Thornton SK, Comis SD, et al., The auditory brainstem response of aged guinea pigs, Acta Otolaryngol (Stockholm) 118, 673-80 (1998).
23. Rybak PR, Whitworth C, Somani S, Application of antioxidants and other agents to prevent cisplatin ototoxicity, Laryngoscope 109, 1740-4 (1999).